Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Genoil Inc GNOLF

Genoil Inc. is technology-based company engaged in the development of technologies relating to the oil and gas industry. The Company specializes in heavy-to-light oil technology, oil field development and exploration and production. It is a provider of hydro conversion fixed-bed technology for the upstream and downstream oil and gas industry. It is also working with Chinese policy banks and Chinese companies to provide, project financing, drilling, production, and processing services to the oil and gas industry. Its technology consists of Genoil Hydroconversion Upgrader (GHU), which converts sour (high sulfur), heavy hydrocarbon feed stocks into lighter oil with higher quality distillates for conventional refining. The Company is also engaged in other technologies, such as oil upgrading and recycling, water purification port technologies, well testing, and sand cleaning. The Company markets its technology to customers in the Middle East, Russia and China.


OTCPK:GNOLF - Post by User

Post by UpPeriscopeon Nov 07, 2021 10:31am
110 Views
Post# 34097272

Scummer-good news, you’re good to go! If I

Scummer-good news, you’re good to go! If I

have no need to flush you gone tomorrow on login, I'll assume you're in line for the shot.

Good on you young man, finally seeing the light.

COVID-19 Vaccines Are Safe for Children and Teens.
Scientists have conducted clinical trials with about 3,000 children and the FDA has determined that the Pfizer-BioNTech COVID-19 Vaccine has met the safety and efficacy standards for authorization in children ages 5 through 15 years.

<< Previous
Bullboard Posts
Next >>